Stonepine Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $8.57M | Sell |
|
|||||
|
2022
Q2 | $8.94M | Buy |
|
|||||
|
2022
Q1 | $8.29M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $32.4M | Buy |
|
|||||
|
2020
Q3 | $30.6M | Buy |
|
|||||
|
2020
Q2 | $10.3M | Sell |
|
|||||
|
2020
Q1 | $11.7M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $2.98M | Sell |
|
|||||
|
2019
Q2 | $19.1M | Buy |
|
|||||
|
2019
Q1 | $18.9M | Buy |
|